Justin M. Burns
Mayo Clinic in Florida · 77 works · 4,908 citations · h-index 26
Top works
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- Normal Intraabdominal Pressure in Healthy Adults
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation
- Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
- Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
- Textile Analysis of Heavy Weight, Mid-Weight, and Light Weight Polypropylene Mesh in a Porcine Ventral Hernia Model
- Cirrhosis is not a contraindication to laparoscopic surgery
- Interleukin‐37 reduces liver inflammatory injury via effects on hepatocytes and non‐parenchymal cells
- In vitro infectability of prosthetic mesh by methicillin-resistant Staphylococcus aureus
- Laparoscopic ventral hernia repair: a single center experience
- Two Novel Assays of Alloantibody-Secreting Cells Demonstrating Resistance to Desensitization With IVIG and rATG
- Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation
- Early Allograft Dysfunction in Liver Transplantation With Donation After Cardiac Death Donors Results in Inferior Survival
- Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity‐matched cohort
- Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States
- Interleukin-33 Is hepatoprotective during liver ischemia/reperfusion in mice
- Intraregional model for end‐stage liver disease score variation in liver transplantation: Disparity in our own backyard
- The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo
- The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma